Vor Biopharma Inc (VOR)

Jan 06, 2026

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com

Jan 06, 2026

Jan 04, 2026

What drives Vor Biopharma Inc stock priceInstitutional Buying Trends & Low Entry Cost Trading - earlytimes.in

Jan 04, 2026

Jan 04, 2026

Ariose Capital Management Ltd Invests $5.37 Million in Vor Biopharma Inc. $VOR - MarketBeat

Jan 04, 2026

Jan 03, 2026

Vor Biopharma Inc Stock Analysis and ForecastSell Signals and Alerts & Free High Yield Growth Strategies - earlytimes.in

Jan 03, 2026

Jan 02, 2026

Aug Macro: Will Vor Biopharma Inc stock outperform international peersFed Meeting & Verified Momentum Stock Watchlist - moha.gov.vn

Jan 02, 2026

Jan 02, 2026

Vor Biopharma CDO Departs, Transition Support Planned - TipRanks

Jan 02, 2026

Jan 02, 2026

Vor Biopharma Target of Unusually High Options Trading (NASDAQ:VOR) - MarketBeat

Jan 02, 2026

Jan 02, 2026

Portfolio Update: How Vor Biopharma Inc. stock benefits from global expansionTrade Risk Report & Fast Entry and Exit Trade Plans - moha.gov.vn

Jan 02, 2026

Dec 31, 2025

Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors - ts2.tech

Dec 31, 2025

Dec 29, 2025

Gap Down: Is Vor Biopharma Inc stock positioned well for digital economyJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - moha.gov.vn

Dec 29, 2025

Dec 28, 2025

Vor Biopharma (VOR) Stock Analysis Report | Financials & Insights - Benzinga

Dec 28, 2025

Dec 27, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 27, 2025

Dec 25, 2025

Moving Averages: How strong is Celsius Holdings Inc stock balance sheet2025 Short Interest & Community Verified Swing Trade Signals - moha.gov.vn

Dec 25, 2025

Dec 25, 2025

Vor Biopharma Stock (+7.4%): New Board Signals Institutional Backing - Trefis

Dec 25, 2025

Dec 24, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Sees Large Growth in Short Interest - MarketBeat

Dec 24, 2025

Dec 23, 2025

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors - The Globe and Mail

Dec 23, 2025

Dec 23, 2025

Vor Biopharma adds two investment partners to board of directors By Investing.com - Investing.com Nigeria

Dec 23, 2025

Dec 23, 2025

Vor Biopharma Inc Announces Board Appointments - marketscreener.com

Dec 23, 2025

Dec 21, 2025

Vor Biopharma Inc.(NasdaqGS: VOR) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

How Vor Biopharma Inc. stock benefits from global expansionIndex Update & Risk Controlled Swing Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

VOR: JP Morgan Lowers Price Target While Maintaining Overweight Rating | VOR Stock News - GuruFocus

Dec 19, 2025

Dec 19, 2025

JPMorgan Chase & Co. Issues Pessimistic Forecast for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat

Dec 19, 2025

Dec 18, 2025

Why Vor Biopharma Inc. stock appeals to dividend seekersJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - ulpravda.ru

Dec 18, 2025

Dec 18, 2025

Vor Biopharma Signs Multiple Financing Agreements - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

Vor Biopharma (VOR) secures $150M private placement and adds two directors - Stock Titan

Dec 18, 2025

Dec 18, 2025

Technical Analysis: Will Vor Biopharma Inc. stock reach all time highs in 2025Earnings Performance Report & Accurate Technical Buy Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Vor Biopharma shares rise after collaborator’s IgAN therapy meets Phase 3 endpoint - MSN

Dec 18, 2025

Dec 17, 2025

Vor Biopharma: Initiating Hold Rating On Durable Telitacicept MG Study Data - Seeking Alpha

Dec 17, 2025

Dec 17, 2025

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential By Investing.com - Investing.com South Africa

Dec 17, 2025

Dec 17, 2025

VOR: TD Cowen Initiates Coverage with a 'Buy' Rating | VOR Stock News - GuruFocus

Dec 17, 2025

Dec 17, 2025

Vor Biopharma (NASDAQ:VOR) Earns Buy Rating from Analysts at TD Cowen - MarketBeat

Dec 17, 2025

Dec 17, 2025

Stocks to watch: Vor Biopharma sees RS rating jump to 89 - MSN

Dec 17, 2025

Dec 17, 2025

TD Cowen Initiates Vor Biopharma at Buy - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential - Investing.com Australia

Dec 17, 2025

Dec 17, 2025

TD Cowen Starts Vor Biopharma, Inc. (VOR) at Buy - StreetInsider

Dec 17, 2025

Dec 16, 2025

Vor Biopharma’s Surge: New Opportunities? - StocksToTrade

Dec 16, 2025

Dec 15, 2025

HC Wainwright & Co. Maintains Vor Biopharma (VOR) Buy Recommendation - MSN

Dec 15, 2025

Dec 15, 2025

Aug Chart Watch: Why Vor Biopharma Inc stock remains resilientPortfolio Performance Report & Free Technical Confirmation Trade Alerts - moha.gov.vn

Dec 15, 2025

Dec 15, 2025

Vor Biopharma Launches $150 Million Private Placement; Shares Rise - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Vor Bio announces $150 million private placement - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Vor Bio announces $150M private placement - MSN

Dec 15, 2025

Dec 15, 2025

Vor Bio Announces $150 Million Private Placement - Yahoo Finance

Dec 15, 2025

Dec 12, 2025

VOR shares rally over 40% in pre-market trade after JPMorgan initiates bullish coverage - MSN

Dec 12, 2025

Dec 12, 2025

Manufacturing Stocks To Keep An Eye OnDecember 9th - MarketBeat

Dec 12, 2025

Dec 12, 2025

Vor Biopharma (VOR) Is Up 45.6% After Telitacicept Phase 3 Win And JPMorgan Nod Has The Bull Case Changed? - Yahoo Finance

Dec 12, 2025

Dec 11, 2025

Vor Biopharma approves stock option repricing plan - MSN

Dec 11, 2025